Back to Screener

Healthcare

Alterity Therapeutics Limited(PRNAF)

Live Price

Offline

$0.055

+0.00% today

1Y Change

-63.33%

Window

Jun 23, 2025 โ†’ Jun 12, 2026

Market Cap
$110.00M
Revenue Growth
+35.3%
EPS Growth
+63.5%
Dividend Yield
0.0%

Coverage: 244 bars ยท Jun 23, 2025 โ†’ Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Alterity Therapeutics Limited (PRNAF) is a Healthcare stock with a market cap of $110.00M and listed on OTC. The stock last traded around $0.06 and down 63.3% across the available one-year price window (Jun 23, 2025 โ†’ Jun 12, 2026). Baseline metrics include revenue growth of +35.3%, EPS growth of +63.5%, a dividend yield of 0.0%. What stands out right now is revenue +35.3%, EPS +63.5%, free cash flow +9.2% with operating margin -525.6% and ROIC -31.3%. Valuation already assumes a fairly strong business story at price/sales 29.8. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PRNAF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

PRNAF

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

PRNAF Max Drawdown

-98.15%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for PRNAF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Next earningsAug 28, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Aug 28, 26
TBD
โ€”
Est -0.00
โ€”
โ€”
Est 1829.0B
โ€”
Aug 28
โ€”
Feb 25, 26
โœ—
-0.00
Est -0.00
-57.9%
607.0B
Est 1006.9B
-39.7%
Feb 25
โ€”
Aug 8, 25
โœ“
-0.00
Est -0.00
+75.8%
1255.6B
Est 5063.4B
-75.2%
Aug 8
โ€”
Feb 28, 25
โœ“
-0.00
Est -0.00
+20.8%
994.0B
Est 2293.4B
-56.7%
Feb 28
โ€”
Aug 29, 24
โœ—
-0.01
Est -0.00
-4872.7%
1412.6B
Est 920.6B
+53.4%
Aug 29
โ€”
Apr 30, 24
โœ“
0.00
Est -0.00
+713.6%
1294.0B
Est 989.9B
+30.7%
Apr 30
โ€”
Aug 31, 23
โœ—
-0.00
Est -0.00
-554.2%
508.2B
Est 1509.8B
-66.3%
Aug 31
โ€”
Dec 31, 22
โœ“
-0.00
Est -0.00
+39.2%
815.2B
Est 1883.4B
-56.7%
Dec 31
โ€”
Jul 22, 22
โœ“
-0.00
Est -0.00
+77.2%
1900.7B
Est 2847.7B
-33.3%
Jul 22
โ€”
Dec 31, 21
-0.00
Est โ€”
โ€”
1710.0B
Est โ€”
โ€”
Dec 31
โ€”
Sep 2, 21
โœ“
-0.00
Est -0.00
+59.3%
1844.1B
Est 1458.0B
+26.5%
Sep 2
โ€”
Apr 29, 21
-0.00
Est โ€”
โ€”
1444.3B
Est โ€”
โ€”
Apr 29
โ€”
Aug 31, 20
-0.01
Est โ€”
โ€”
-1285.4B
Est โ€”
โ€”
Aug 31
โ€”
Feb 27, 20
-0.00
Est โ€”
โ€”
1304.8B
Est โ€”
โ€”
Feb 27
โ€”
Aug 30, 19
โœ—
-0.01
Est -0.00
-67.2%
1764.8B
Est 952.3B
+85.3%
Aug 30
โ€”
Dec 31, 18
-0.01
Est โ€”
โ€”
1876.4B
Est โ€”
โ€”
Dec 31
โ€”
Jun 30, 18
-0.01
Est โ€”
โ€”
1213.3B
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 17
-0.01
Est โ€”
โ€”
1138.0B
Est โ€”
โ€”
Dec 31
โ€”
Jun 30, 17
-0.01
Est โ€”
โ€”
958.0B
Est โ€”
โ€”
Jun 30
โ€”
Dec 31, 16
-0.00
Est โ€”
โ€”
1370.8B
Est โ€”
โ€”
Dec 31
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener